SLCTR/2021/021RecruitingPhase 2
A single-center, randomized, six month, parallel-group, study to compare the effectiveness of a combination of physiotherapy and Ayurveda treatment versus physiotherapy and placebo in ischemic stroke rehabilitation.
Higher degree, Research and Publication Committee0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients confirmed to have an ischemic stroke
- •Patients above 18 years of age
- •* Both men and women
- •Barthel Index 0-50 (severely disabled patients)
- •NIHSS score (The National Institutes of Health Stroke Scale Score) 5-20 on admission.
- •Non- thrombolysis patients
Exclusion Criteria
- •Stroke mimics (A nonvascular disease that presents with stroke-like symptoms, often indistinguishable from an actual stroke)
- •Eg: brain tumors (gliomas, meningiomas, adenomas)
- •* Toxic/ metabolic disorders ( hypoglycemia, hypercalcemia, hyponatremia, uremia, hepatic encephalopathy, hyperthyroidism, thyroid storm)
- •* Infectious disorders (meningio encephalitis)
- •* Psychological disorders
- •* Migraines
- •* Seizures
- •* Demyelination disorders
- •Posterior circulation stroke
- •Hemorrhagic strokes
- •Patients without a caregiver, relative or a supporting family
Investigators
Similar Trials
Active, not recruiting
Not Applicable
A 6 months, multicenter study to evaluate the effect of an individualized patient support program on treatment satisfaction in Fingolimod (FTY720)-treated patients with relapsing-remitting multiple sclerosisTreatment statisfaction in patients with relapsing remitting Multiple SclerosisMedDRA version: 15.0Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2012-002637-11-DEovartis Pharma GmbH
Completed
Not Applicable
Changes in Resting Energy Expenditure with Two Different Schedules of Calorie RestrictioObesityACTRN12617000635369Assoc Prof Jeremy Krebs36
Active, not recruiting
Not Applicable
A 6-month, multicenter, randomized, controlled parallel group study to evaluate the effect of physical training on fatigue in patients with relapsing-remitting multiple sclerosis treated with fingolimod (Gilenya®), followed by a 6 month optional extension phaseEUCTR2011-002969-38-DEovartis Pharma GmbH
Active, not recruiting
Phase 1
Combination treatment with dapagliflozin and exenatide to investigate the effect of weight loss in subjects with obesity compared to placebo.Obesity defined as body mass index (BMI) 30-45 kg/m2Obesity related metabolic disordersMedDRA version: 18.0Level: LLTClassification code 10029885Term: Obesity, unspecifiedSystem Organ Class: 100000004861EUCTR2014-003432-39-SEDept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University
Completed
Phase 3
BE study of Budesonide 80 µg and Formoterol Fumarate Dihydrate 4.5 µg inhalation product in asthma patientCTRI/2022/08/044640Cipla Ltd1,191